416 results on '"Keung, Emily"'
Search Results
2. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma
3. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
4. ASO Visual Abstract: Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas)—Single-Institution Study of 95 Surgical Patients
5. ASO Visual Abstract: High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival Following Resection of Extremity and Truncal Soft-Tissue Sarcoma
6. Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership
7. Myxoid Liposarcomas: Systemic Treatment Options
8. SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection
9. Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature
10. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma
11. Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease
12. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes
13. Neoadjuvant relatlimab and nivolumab in resectable melanoma
14. Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases
15. B cells and tertiary lymphoid structures promote immunotherapy response
16. Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients
17. Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
18. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
19. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
20. ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membership
21. ASO Author Reflections: Variability in Management of Sarcoma Lymph Node Metastases
22. Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020
23. Management of Skin Sarcomas
24. Practical Management of Melanoma
25. ASO Author Reflections: A Call for Consensus, Collaboration and Data on the Role of Sentinel Lymph Node Biopsy for Soft Tissue Sarcoma
26. ASO Visual Abstract: Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas—A Systematic Review of the Literature
27. ASO Visual Abstract: Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma
28. Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver.
29. Neoadjuvant Systemic Therapy for High-Risk Melanoma Patients
30. Melanoma Prognosis and Staging
31. Defining the Study Cohort: Inclusion and Exclusion Criteria
32. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state
33. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era
34. ASO Visual Abstract: Sentinel Lymph Node Biopsy and Formal Lymphadenectomy For Soft Tissue Sarcoma: A Single-Center Experience of 86 Consecutive Cases
35. Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities
36. Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma
37. Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
38. ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease
39. Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression
40. ASO Visual Abstract: Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients
41. Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum
42. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience.
43. ASO Author Reflections: Lymph Node Disease in Soft Tissue Sarcoma: A Problematic Clinical Dilemma
44. The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors
45. Dual Roles of RNF2 in Melanoma Progression
46. B cells are associated with survival and immunotherapy response in sarcoma
47. The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies
48. The Future of Targeted Therapy for Leiomyosarcoma.
49. The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition
50. Defining the Study Cohort: Inclusion and Exclusion Criteria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.